Chemours Statistics
Share Statistics
Chemours has 149.67M
shares outstanding. The number of shares has increased by 0.37%
in one year.
| Shares Outstanding | 149.67M |
| Shares Change (YoY) | 0.37% |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | 84.19% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,870 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 12.74M, so 8.51% of the outstanding
shares have been sold short.
| Short Interest | 12.74M |
| Short % of Shares Out | 8.51% |
| Short % of Float | 12.51% |
| Short Ratio (days to cover) | 5.45 |
Valuation Ratios
The PE ratio is 29.38 and the forward
PE ratio is 4.
Chemours's PEG ratio is
-0.22.
| PE Ratio | 29.38 |
| Forward PE | 4 |
| PS Ratio | 0.44 |
| Forward PS | 0.3 |
| PB Ratio | 4.18 |
| P/FCF Ratio | -2.54 |
| PEG Ratio | -0.22 |
Financial Ratio HistoryEnterprise Valuation
Chemours has an Enterprise Value (EV) of 6.17B.
| EV / Sales | 1.07 |
| EV / EBITDA | 8.91 |
| EV / EBIT | -9.74 |
| EV / FCF | -6.21 |
Financial Position
The company has a current ratio of 1.68,
with a Debt / Equity ratio of 7.21.
| Current Ratio | 1.68 |
| Quick Ratio | 0.86 |
| Debt / Equity | 7.21 |
| Debt / EBITDA | 6.29 |
| Debt / FCF | -4.39 |
| Interest Coverage | 1.73 |
Financial Efficiency
Return on Equity is 14.24% and Return on Invested Capital is 5.37%.
| Return on Equity | 14.24% |
| Return on Assets | 1.14% |
| Return on Invested Capital | 5.37% |
| Revenue Per Employee | $963,666.67 |
| Profits Per Employee | $14,333.33 |
| Employee Count | 6,000 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 3.15 |
Taxes
| Income Tax | 41M |
| Effective Tax Rate | 32.28% |
Stock Price Statistics
The stock price has increased by -58.34% in the
last 52 weeks. The beta is 1.74, so Chemours's
price volatility has been higher than the market average.
| Beta | 1.74 |
| 52-Week Price Change | -58.34% |
| 50-Day Moving Average | 12.68 |
| 200-Day Moving Average | 17.44 |
| Relative Strength Index (RSI) | 49.03 |
| Average Volume (20 Days) | 3,267,427 |
Income Statement
In the last 12 months, Chemours had revenue of 5.78B
and earned 86M
in profits. Earnings per share was 0.58.
| Revenue | 5.78B |
| Gross Profit | 1.15B |
| Operating Income | 457M |
| Net Income | 86M |
| EBITDA | 692M |
| EBIT | 391M |
| Earnings Per Share (EPS) | 0.58 |
Full Income StatementBalance Sheet
The company has 713M in cash and 4.36B in
debt, giving a net cash position of -3.64B.
| Cash & Cash Equivalents | 713M |
| Total Debt | 4.36B |
| Net Cash | -3.64B |
| Retained Earnings | 1.72B |
| Total Assets | 7.51B |
| Working Capital | 1.22B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -633M
and capital expenditures -360M, giving a free cash flow of -993M.
| Operating Cash Flow | -633M |
| Capital Expenditures | -360M |
| Free Cash Flow | -993M |
| FCF Per Share | -6.64 |
Full Cash Flow StatementMargins
Gross margin is 19.91%, with operating and profit margins of 7.9% and 1.49%.
| Gross Margin | 19.91% |
| Operating Margin | 7.9% |
| Pretax Margin | 2.2% |
| Profit Margin | 1.49% |
| EBITDA Margin | 11.97% |
| EBIT Margin | 7.9% |
| FCF Margin | -17.17% |
